Objective
Type 1 diabetes is a common chronic disease mainly arising in children and young people. In Europe, its incidence is high and steadily increasing. The disease is caused by the destruction of insulin-producing cells in the pancreas. Many studies have suggested that enterovirus infections can induce this process. Recently, substantial new evidence has been obtained further supporting their role. This study aims to confirm the link between enterovirus infections and Type 1diabetes in five EU countries and characterize the molecular determinants, which make these viruses diabetogenic. The final goal is to find out if Type 1 diabetes can be prevented by an enterovirus vaccine and provide information needed for the development of such vaccines.
Fields of science
Call for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
33014 Tampere
Finland
See on map
Participants (6)
59037 Lille
See on map
SE1 7EH London
See on map
581 85 Linkoeping
See on map
11527 Athens
See on map
E1 2BB London
See on map
CO4 3SQ Colchester
See on map